In Vitro Fertilization Test Market (By Test Type: Sperm Aneuploidy Test, Genetic Compatibility Test, Preimplantation Genetic Testing, Endometrial Receptivity Analysis, and Others; By End User: Fertility Clinics, Hospitals, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global In Vitro Fertilization Test Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Introduction

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global In Vitro Fertilization Test Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Key Mergers & Acquisitions

    5.2. COVID-19 Pandemics Impact on Industry (Value Chain and Short / Mid /Long Term Impact)

    5.3. Regulatory Scenario by Region/globally

    5.4. Top 3 players operating in the market space

    5.5. Key product/brand Analysis

6. Global In Vitro Fertilization Test Market Analysis and Forecast, by Test Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Test Type, 2017–2031

        6.3.1. Sperm Aneuploidy Test

        6.3.2. Genetic Compatibility Test

        6.3.3. Preimplantation Genetic Testing 

        6.3.4. Endometrial Receptivity Analysis

        6.3.5. Noninvasive Prenatal Testing

        6.3.6. Others

    6.4. Market Attractiveness Analysis, by Test Type 

7. Global In Vitro Fertilization Test Market Analysis and Forecast, by End-user

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by End-user, 2017–2031

        7.3.1. Fertility Clinics

        7.3.2. Hospitals

        7.3.3. Others

    7.4. Market Attractiveness Analysis, by End-user 

8. Global In Vitro Fertilization Test Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast by Region

        8.2.1. North America 

        8.2.2. Europe 

        8.2.3. Asia Pacific 

        8.2.4. Latin America 

        8.2.5. Middle East & Africa 

    8.3. Market Attractiveness Analysis, by Country/Region

9. North America In Vitro Fertilization Test Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Test Type, 2017–2031

        9.2.1. Sperm Aneuploidy Test

        9.2.2. Genetic Compatibility Test

        9.2.3. Preimplantation Genetic Testing 

        9.2.4. Endometrial Receptivity Analysis

        9.2.5. Noninvasive Prenatal Testing

        9.2.6. Others

    9.3. Market Value Forecast, by End-user, 2017–2031

        9.3.1. Fertility Clinics

        9.3.2. Hospitals

        9.3.3. Others

    9.4. Market Value Forecast, by Country, 2017–2031

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis 

        9.5.1. By Test Type 

        9.5.2. By End-user 

        9.5.3. By Country

10. Europe In Vitro Fertilization Test Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Test Type, 2017–2031

        10.2.1. Sperm Aneuploidy Test

        10.2.2. Genetic Compatibility Test

        10.2.3. Preimplantation Genetic Testing 

        10.2.4. Endometrial Receptivity Analysis

        10.2.5. Noninvasive Prenatal Testing

        10.2.6. Others

    10.3. Market Value Forecast, by End-user, 2017–2031

        10.3.1. Fertility Clinics

        10.3.2. Hospitals

        10.3.3. Others

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis 

        10.5.1. By Test Type 

        10.5.2. By End-user 

        10.5.3. By Country/Sub-region

11. Asia Pacific In Vitro Fertilization Test Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Test Type, 2017–2031

        11.2.1. Sperm Aneuploidy Test

        11.2.2. Genetic Compatibility Test

        11.2.3. Preimplantation Genetic Testing 

        11.2.4. Endometrial Receptivity Analysis

        11.2.5. Noninvasive Prenatal Testing

        11.2.6. Others

    11.3. Market Value Forecast, by End-user, 2017–2031

        11.3.1. Fertility Clinics

        11.3.2. Hospitals

        11.3.3. Others

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis 

        11.5.1. By Test Type 

        11.5.2. By End-user 

        11.5.3. By Country/Sub-region

12. Latin America In Vitro Fertilization Test Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Test Type, 2017–2031

        12.2.1. Sperm Aneuploidy Test

        12.2.2. Genetic Compatibility Test

        12.2.3. Preimplantation Genetic Testing 

        12.2.4. Endometrial Receptivity Analysis

        12.2.5. Noninvasive Prenatal Testing

        12.2.6. Others

    12.3. Market Value Forecast, by End-user, 2017–2031

        12.3.1. Fertility Clinics

        12.3.2. Hospitals

        12.3.3. Others

    12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis 

        12.5.1. By Test Type 

        12.5.2. By End-user 

        12.5.3. By Country/Sub-region

13. Middle East & Africa In Vitro Fertilization Test Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Test Type, 2017–2031

        13.2.1. Sperm Aneuploidy Test

        13.2.2. Genetic Compatibility Test

        13.2.3. Preimplantation Genetic Testing 

        13.2.4. Endometrial Receptivity Analysis

        13.2.5. Noninvasive Prenatal Testing

        13.2.6. Others

    13.3. Market Value Forecast, by End-user, 2017–2031

        13.3.1. Fertility Clinics

        13.3.2. Hospitals

        13.3.3. Others

    13.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis 

        13.5.1. By Test Type 

        13.5.2. By End-user 

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by Tier and Size of companies)

    14.2. Market Share Analysis, by Company, 2020

    14.3. Company Profiles

        14.3.1. CooperSurgical, Inc.

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Growth Strategies

            14.3.1.3. SWOT Analysis

        14.3.2. Esco Micro Pte Ltd.

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Growth Strategies

            14.3.2.3. SWOT Analysis

        14.3.3. FUJIFILM Irvine Scientific

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Growth Strategies

            14.3.3.3. SWOT Analysis

        14.3.4. Hamilton Thorne, Inc.

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Growth Strategies

            14.3.4.3. SWOT Analysis

        14.3.5. Vitrolife AB

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Growth Strategies

            14.3.5.3. SWOT Analysis

        14.3.6. IVFtech ApS

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Growth Strategies

            14.3.6.3. SWOT Analysis

        14.3.7. Nidacon International AB 

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Growth Strategies

            14.3.7.3. SWOT Analysis

        14.3.8. Igenomix

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Growth Strategies

            14.3.8.3. SWOT Analysis

        14.3.9. Thermo Fisher Scientific

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Growth Strategies

            14.3.9.3. SWOT Analysis

        14.3.10. Cook

            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.10.2. Growth Strategies

            14.3.10.3. SWOT Analysis

        14.3.11. Genea Biomedx

            14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.11.2. Growth Strategies

            14.3.11.3. SWOT Analysis

        14.3.12. FertiPro N.V

            14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.12.2. Growth Strategies

            14.3.12.3. SWOT Analysis

        14.3.13. Kitazato Corporation

            14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.13.2. Growth Strategies

            14.3.13.3. SWOT Analysis

        14.3.14. PerkinElmer, Inc.

            14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.14.2. Growth Strategies

            14.3.14.3. SWOT Analysis

        14.3.15. Natera

            14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.15.2. Growth Strategies

            14.3.15.3. SWOT Analysis

        14.3.16. Takara Bio, Inc.

            14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.16.2. Growth Strategies

            14.3.16.3. SWOT Analysis

        14.3.17. iGLS

            14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.17.2. Growth Strategies

            14.3.17.3. SWOT Analysis

        14.3.18. CiceroDx

            14.3.18.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.18.2. Growth Strategies

            14.3.18.3. SWOT Analysis

Report Details

  • Report Code:38159
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Published:July 2021
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers